Published in Pharmacoepidemiol Drug Saf on July 01, 2010
Comparative cardiovascular effects of thiazolidinediones: systematic review and meta-analysis of observational studies. BMJ (2011) 4.05
Noninsulin glucose-lowering agents for the treatment of patients on dialysis. Nat Rev Nephrol (2013) 0.99
Utilisation trends of rosiglitazone and pioglitazone in Australia before and after safety warnings. BMC Health Serv Res (2014) 0.89
Risk of death and cardiovascular outcomes with thiazolidinediones: a study with the general practice research database and secondary care data. PLoS One (2011) 0.86
Cardiovascular risk associated with the use of glitazones, metformin and sufonylureas: meta-analysis of published observational studies. BMC Cardiovasc Disord (2016) 0.75
Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes. N Engl J Med (2007) 33.21
Pioglitazone and risk of cardiovascular events in patients with type 2 diabetes mellitus: a meta-analysis of randomized trials. JAMA (2007) 5.89
Congestive heart failure and cardiovascular death in patients with prediabetes and type 2 diabetes given thiazolidinediones: a meta-analysis of randomised clinical trials. Lancet (2007) 5.74
Long-term risk of cardiovascular events with rosiglitazone: a meta-analysis. JAMA (2007) 5.02
Adverse cardiovascular events during treatment with pioglitazone and rosiglitazone: population based cohort study. BMJ (2009) 4.44
Thiazolidinediones and cardiovascular outcomes in older patients with diabetes. JAMA (2007) 4.25
The need for large-scale randomized evidence without undue emphasis on small trials, meta-analyses, or subgroup analyses. JAMA (2009) 3.58
The Translating Research Into Action for Diabetes (TRIAD) study: a multicenter study of diabetes in managed care. Diabetes Care (2002) 2.72
Diabetes reporting as a cause of death: results from the Translating Research Into Action for Diabetes (TRIAD) study. Diabetes Care (2006) 2.36
A comparison of pioglitazone and rosiglitazone for hospitalization for acute myocardial infarction in type 2 diabetes. Pharmacoepidemiol Drug Saf (2007) 2.10
The risk of developing coronary artery disease or congestive heart failure, and overall mortality, in type 2 diabetic patients receiving rosiglitazone, pioglitazone, metformin, or sulfonylureas: a retrospective analysis. Acta Diabetol (2009) 1.69
Comparison of cardiovascular outcomes in elderly patients with diabetes who initiated rosiglitazone vs pioglitazone therapy. Arch Intern Med (2008) 1.45
Relationship between thiazolidinedione use and cardiovascular outcomes and all-cause mortality among patients with diabetes: a time-updated propensity analysis. Pharmacoepidemiol Drug Saf (2009) 1.18
Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy. N Engl J Med (2006) 19.09
Low-fat dietary pattern and risk of cardiovascular disease: the Women's Health Initiative Randomized Controlled Dietary Modification Trial. JAMA (2006) 12.44
Calcium plus vitamin D supplementation and the risk of fractures. N Engl J Med (2006) 12.09
Estrogen plus progestin and the risk of coronary heart disease. N Engl J Med (2003) 10.06
Calcium plus vitamin D supplementation and the risk of colorectal cancer. N Engl J Med (2006) 8.73
Ethnic disparities in diabetic complications in an insured population. JAMA (2002) 8.28
The importance of race and ethnic background in biomedical research and clinical practice. N Engl J Med (2003) 7.94
Abdominal sacrocolpopexy with Burch colposuspension to reduce urinary stress incontinence. N Engl J Med (2006) 7.42
Diabetes care quality in the Veterans Affairs Health Care System and commercial managed care: the TRIAD study. Ann Intern Med (2004) 6.77
Effect of intensity of oral anticoagulation on stroke severity and mortality in atrial fibrillation. N Engl J Med (2003) 6.70
Low-fat dietary pattern and risk of invasive breast cancer: the Women's Health Initiative Randomized Controlled Dietary Modification Trial. JAMA (2006) 6.51
Guidelines for improving the care of the older person with diabetes mellitus. J Am Geriatr Soc (2003) 6.50
Effectiveness of pharmacist care for patients with reactive airways disease: a randomized controlled trial. JAMA (2002) 5.80
Hypoglycemic episodes and risk of dementia in older patients with type 2 diabetes mellitus. JAMA (2009) 5.75
Translating the Diabetes Prevention Program into the community. The DEPLOY Pilot Study. Am J Prev Med (2008) 5.40
A meta-analysis of interventions to improve care for chronic illnesses. Am J Manag Care (2005) 5.10
A new look at screening and diagnosing diabetes mellitus. J Clin Endocrinol Metab (2008) 4.97
Microalbuminuria in the US population: third National Health and Nutrition Examination Survey. Am J Kidney Dis (2002) 4.34
Anticoagulation therapy for stroke prevention in atrial fibrillation: how well do randomized trials translate into clinical practice? JAMA (2003) 4.13
The Diabetes Prevention Program: recruitment methods and results. Control Clin Trials (2002) 4.03
Why don't diabetes patients achieve recommended risk factor targets? Poor adherence versus lack of treatment intensification. J Gen Intern Med (2008) 3.99
Socioeconomic position and health among persons with diabetes mellitus: a conceptual framework and review of the literature. Epidemiol Rev (2004) 3.74
Therapy modifications in response to poorly controlled hypertension, dyslipidemia, and diabetes mellitus. Ann Intern Med (2006) 3.71
Disparities in HbA1c levels between African-American and non-Hispanic white adults with diabetes: a meta-analysis. Diabetes Care (2006) 3.67
Rosiglitazone-associated fractures in type 2 diabetes: an Analysis from A Diabetes Outcome Progression Trial (ADOPT). Diabetes Care (2008) 3.45
A multicenter study of the outcome of biliary atresia in the United States, 1997 to 2000. J Pediatr (2006) 3.32
What is the concordance between the medical record and patient self-report as data sources for ambulatory care? Med Care (2006) 3.27
Do older adults expect to age successfully? The association between expectations regarding aging and beliefs regarding healthcare seeking among older adults. J Am Geriatr Soc (2002) 3.26
The direct medical cost of type 2 diabetes. Diabetes Care (2003) 3.23
Effect of prior intensive insulin treatment during the Diabetes Control and Complications Trial (DCCT) on peripheral neuropathy in type 1 diabetes during the Epidemiology of Diabetes Interventions and Complications (EDIC) Study. Diabetes Care (2010) 3.20
Patient quality of life during the 12 months following joint replacement surgery. Arthritis Rheum (2004) 3.16
Race, ethnicity, socioeconomic position, and quality of care for adults with diabetes enrolled in managed care: the Translating Research Into Action for Diabetes (TRIAD) study. Diabetes Care (2005) 3.09
Evaluation of a behavior support intervention for patients with poorly controlled diabetes. Arch Intern Med (2011) 3.09
Social disparities in internet patient portal use in diabetes: evidence that the digital divide extends beyond access. J Am Med Inform Assoc (2011) 3.07
Central nervous system-active medications and risk for falls in older women. J Am Geriatr Soc (2002) 3.03
Incidence and prognosis of resistant hypertension in hypertensive patients. Circulation (2012) 2.99
Low-fat dietary pattern and risk of colorectal cancer: the Women's Health Initiative Randomized Controlled Dietary Modification Trial. JAMA (2006) 2.97
The literacy divide: health literacy and the use of an internet-based patient portal in an integrated health system-results from the diabetes study of northern California (DISTANCE). J Health Commun (2010) 2.97
Prevalence and determinants of insulin resistance among U.S. adolescents: a population-based study. Diabetes Care (2006) 2.84
Looking forward, looking back: assessing variations in hospital resource use and outcomes for elderly patients with heart failure. Circ Cardiovasc Qual Outcomes (2009) 2.80
ADHD medications and risk of serious cardiovascular events in young and middle-aged adults. JAMA (2011) 2.77
Missed appointments and poor glycemic control: an opportunity to identify high-risk diabetic patients. Med Care (2004) 2.73
Cost-lowering strategies used by medicare beneficiaries who exceed drug benefit caps and have a gap in drug coverage. JAMA (2004) 2.66
Neuropathy among the diabetes control and complications trial cohort 8 years after trial completion. Diabetes Care (2006) 2.64
Prediction of type 2 diabetes mellitus with alternative definitions of the metabolic syndrome: the Insulin Resistance Atherosclerosis Study. Circulation (2005) 2.63
New prescription medication gaps: a comprehensive measure of adherence to new prescriptions. Health Serv Res (2009) 2.63
Cohort Profile: The Diabetes Study of Northern California (DISTANCE)--objectives and design of a survey follow-up study of social health disparities in a managed care population. Int J Epidemiol (2008) 2.59
Two-year outcomes after sacrocolpopexy with and without burch to prevent stress urinary incontinence. Obstet Gynecol (2008) 2.58
Valuing health-related quality of life in diabetes. Diabetes Care (2002) 2.55
Glycated hemoglobin assessment in clinical practice: comparison of the A1cNow point-of-care device with central laboratory testing (GOAL A1C Study). Diabetes Technol Ther (2005) 2.54
Racial/ethnic variation in asthma status and management practices among children in managed medicaid. Pediatrics (2002) 2.54
Mail-order pharmacy use and adherence to diabetes-related medications. Am J Manag Care (2010) 2.51
Communication and medication refill adherence: the Diabetes Study of Northern California. JAMA Intern Med (2013) 2.44
Longitudinal study of new and prevalent use of self-monitoring of blood glucose. Diabetes Care (2006) 2.44
Elevated depression symptoms, antidepressant medicine use, and risk of developing diabetes during the diabetes prevention program. Diabetes Care (2007) 2.42
The bone diagnostic instrument II: indentation distance increase. Rev Sci Instrum (2008) 2.40
Do patient consent procedures affect participation rates in health services research? Med Care (2002) 2.38
Adapting the Diabetes Prevention Program lifestyle intervention for delivery in the community: the YMCA model. Diabetes Educ (2007) 2.37
Diabetes reporting as a cause of death: results from the Translating Research Into Action for Diabetes (TRIAD) study. Diabetes Care (2006) 2.36
Multimarker prediction of coronary heart disease risk: the Women's Health Initiative. J Am Coll Cardiol (2010) 2.34
The association between quality of care and the intensity of diabetes disease management programs. Ann Intern Med (2006) 2.32
Current use of unopposed estrogen and estrogen plus progestin and the risk of acute myocardial infarction among women with diabetes: the Northern California Kaiser Permanente Diabetes Registry, 1995-1998. Circulation (2003) 2.32
Does literacy mediate the relationship between education and health outcomes? A study of a low-income population with diabetes. Public Health Rep (2006) 2.30
Central nervous system active medications and risk for fractures in older women. Arch Intern Med (2003) 2.30
Fecal and urinary incontinence in primiparous women. Obstet Gynecol (2006) 2.28
Social network analysis as an analytic tool for interaction patterns in primary care practices. Ann Fam Med (2005) 2.26
Building an academic-community partnered network for clinical services research: the Community Health Improvement Collaborative (CHIC). Ethn Dis (2006) 2.25
System-based participatory research in health care: an approach for sustainable translational research and quality improvement. Ann Fam Med (2010) 2.24
Methodological challenges associated with patient responses to follow-up longitudinal surveys regarding quality of care. Health Serv Res (2003) 2.21
Cost-effectiveness of screening for pre-diabetes among overweight and obese U.S. adults. Diabetes Care (2007) 2.20
Case-control single-marker and haplotypic association analysis of pedigree data. Genet Epidemiol (2005) 2.19
Diabetes and incidence of functional disability in older women. Diabetes Care (2002) 2.16
Metformin prescription for insured adults with prediabetes from 2010 to 2012: a retrospective cohort study. Ann Intern Med (2015) 2.16
Impact of a program to improve adherence to diabetes guidelines by primary care physicians. Diabetes Care (2002) 2.14
Diabetes and progression of carotid atherosclerosis: the insulin resistance atherosclerosis study. Arterioscler Thromb Vasc Biol (2003) 2.12
The perceived impact of disclosure of pediatric HIV status on pediatric antiretroviral therapy adherence, child well-being, and social relationships in a resource-limited setting. AIDS Patient Care STDS (2010) 2.07
Partnering with community-based organizations: an academic institution's evolving perspective. Ethn Dis (2007) 2.05
Managing preexisting diabetes for pregnancy: summary of evidence and consensus recommendations for care. Diabetes Care (2008) 2.04
Glycemic control, complications, and death in older diabetic patients: the diabetes and aging study. Diabetes Care (2011) 2.04
Opportunistic screening for diabetes in routine clinical practice. Diabetes Care (2004) 2.03
Risk perception for diabetes among women with histories of gestational diabetes mellitus. Diabetes Care (2007) 2.02
Prevalence of osteonecrosis of the jaw in patients with oral bisphosphonate exposure. J Oral Maxillofac Surg (2009) 2.00
The association of religiosity with overweight/obese body mass index among Asian Indian immigrants in California. Prev Med (2013) 1.99
Patient-centered medical home intervention at an internal medicine resident safety-net clinic. JAMA Intern Med (2013) 1.98
Epidemiology and adverse cardiovascular risk profile of diagnosed polycystic ovary syndrome. J Clin Endocrinol Metab (2006) 1.96
Risk factors for mortality among patients with diabetes: the Translating Research Into Action for Diabetes (TRIAD) Study. Diabetes Care (2007) 1.95
Race/ethnicity and economic differences in cost-related medication underuse among insured adults with diabetes: the Translating Research Into Action for Diabetes Study. Diabetes Care (2007) 1.95